Thursday, October 8, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· July 14, 2026

Progress on share buyback programme

View original at globenewswire.com
Progress on share buyback programme Progress on share buyback programme ING announced today that, as part of our €1.0 billion share buyback programme announced on 30 April 2026, in total 950,000 shares were repurchased during the week of 6 July up to and including 10 July 2026…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • ING is a global financial institution with a strong European base, offering banking services through its operating company ING Bank; ING Bank's purpose is empowering people to stay a step ahead in life and in business, with more than 60,000 employees serving customers in over 100 countries.

    60% confidence
  • The total number of shares repurchased under this programme to date is 14,960,000 at an average price of €26.23 for a total consideration of €392,360,769.50; approximately 39.24% of the maximum total value of the share buyback programme has been completed.

    60% confidence
  • ING's ESG rating by MSCI was upgraded from 'AA' to 'AAA' in October 2025.

    60% confidence
  • As part of ING's €1.0 billion share buyback programme announced on 30 April 2026, in total 950,000 shares were repurchased during the week of 6 July up to and including 10 July 2026, at an average price of €28.41 for a total amount of €26,985,940.00.

    60% confidence
  • As of June 2025, in Sustainalytics' view, ING's management of ESG material risk is 'Strong' with an ESG risk rating of 18.0 (low risk).

    60% confidence

Data points we hold from this source

ING Group · buyback amount weekly26985940.00 EUR
ING Group · average repurchase price weekly28.41 EUR
ING Group · cumulative average repurchase price26.23 EUR
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,362 source documents archived
Query this data → isubstrate.com
Progress on share buyback programme — Source | Via News | ViaNews Market